Journal article

Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant

Nicholas A Keks, Judy Hope, Simone Keogh, David L Copolov

Australasian Psychiatry | SAGE PUBLICATIONS LTD | Published : 2018

DOI: 10.1177/1039856218794874

University of Melbourne Researchers

Citation metrics

2Web of Science
2Scopus
2Dimensions

Keywords

Humans
Milnacipran
Fibromyalgia
Mood
Major Depressive Disorder
Life Sciences & Biomedicine
Guidelines
Antidepressant
Depressive Disorder, Major
Science & Technology
Psychiatry
Snri
Serotonin and Noradrenaline Reuptake Inhibitors
Efficacy